var data={"title":"Clindamycin and benzoyl peroxide: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Clindamycin and benzoyl peroxide: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/5918?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=clindamycin-and-benzoyl-peroxide-patient-drug-information\" class=\"drug drug_patient\">see &quot;Clindamycin and benzoyl peroxide: Patient drug information&quot;</a> and <a href=\"topic.htm?path=clindamycin-and-benzoyl-peroxide-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Clindamycin and benzoyl peroxide: Pediatric drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F152776\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Acanya;</li>\n      <li>BenzaClin;</li>\n      <li>Duac;</li>\n      <li>Neuac;</li>\n      <li>Onexton</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F854892\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>BenzaClin;</li>\n      <li>Clindoxyl</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F152791\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Acne Products;</li>\n      <li>\n        Topical Skin Product;</li>\n      <li>\n        Topical Skin Product, Acne</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F152779\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Acne:</b>  Topical:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Clindamycin 1.2%/benzoyl peroxide 2.5%:</i> Apply pea-sized amount to affected area once daily; use &gt;12 weeks has not been studied.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Clindamycin 1.2%/benzoyl peroxide 3.75%:</i> Apply pea-sized amount to affected area once daily; use &gt;12 weeks has not been studied.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Clindamycin 1%/benzoyl peroxide 5%:</i> Apply to affected area twice daily (morning and evening).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Inflammatory acne:</b>  Topical: <i>Clindamycin 1.2%/benzoyl peroxide 5%:</i> Apply to affected area once daily in the evening.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Rosacea (off-label use): </b>Topical: <i>Clindamycin 1%/benzoyl peroxide 5%:</i> Apply to affected area once daily for 12 weeks (Leyden 2004)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F152786\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span><p>(For additional information <a href=\"topic.htm?path=clindamycin-and-benzoyl-peroxide-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Clindamycin and benzoyl peroxide: Pediatric drug information&quot;</a>)</p>\n    <p style=\"text-indent:0em;display:inline\">Children &ge;12 years and Adolescents: Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F152780\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50109320\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;\">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50109321\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;\">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F152760\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gel, topical:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Acanya: Clindamycin phosphate 1.2% and benzoyl peroxide 2.5% (50 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">BenzaClin: Clindamycin 1% and benzoyl peroxide 5% (25 g, 35 g, 50 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Duac: Clindamycin phosphate 1.2% and benzoyl peroxide 5% (45 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Neuac: Clindamycin phosphate 1.2% and benzoyl peroxide 5% (45 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Onexton: Clindamycin phosphate 1.2% and benzoyl peroxide 3.75% (50 g) [contains propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Generic: Clindamycin 1% and benzoyl peroxide 5% (25 g, 35 g, 50 g); Clindamycin phosphate 1.2% and benzoyl peroxide 5% (45 g)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F152748\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">Yes</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F152762\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Skin should be clean and dry before applying. For external use only; avoid applying to inside nose, mouth, eyes, vagina, mucous membranes, and on areas of broken skin. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F152761\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Acne:</b> Topical treatment of acne vulgaris</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25873030\" class=\"block off-label drugH1Div\"><span class=\"drugH1\">Use: Off-Label</span>\n    <p>Rosacea</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F152754\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">Also see individual agents.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">&gt;10%:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Dermatologic: Application site scaling (&le;21%), local dryness (&le;16%)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Local: Application site erythema (&lt;31%), local desquamation (2% to 19%), application site itching (&le;17%)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">1% to 10%:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Dermatologic: Stinging of the skin (application site: &le;7%), sunburn (local; 1%)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Local: Application site burning (&le;10%), application site reaction (3%)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">&lt;1%, postmarketing, and/or case reports: Anaphylaxis, application site irritation, application site pain, contact dermatitis, hypersensitivity reaction, local discoloration, local skin exfoliation, skin rash, urticaria</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F152765\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Hypersensitivity to benzoyl peroxide, clindamycin, lincomycin, or any component of the formulation; history of regional enteritis, ulcerative colitis, pseudomembranous colitis or antibiotic-associated colitis </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F152752\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Bleaching effects: Benzoyl peroxide may bleach hair, colored fabric, or carpeting.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Diarrhea: Systemic absorption may occur after topical use of clindamycin. <i>C. difficile</i>-associated diarrhea (CDAD) and pseudomembranous colitis have been reported and have been observed &gt;2 months postantibiotic treatment. Use of parenteral and systemic clindamycin has resulted in severe colitis (including fatalities). Discontinue drug if significant diarrhea, abdominal cramps, or passage of blood and mucus occurs.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Hypersensitivity: Anaphylaxis and allergic reactions have been reported, may occur within minutes to a day or longer, and differ from local skin irritation.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Skin irritation: Use concomitant topical acne therapy with caution; cumulative irritancy may occur, especially with the use of peeling, desquamating, or abrasive agents.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concurrent drug therapy issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Drug-drug interactions: Potentially significant interactions may exist, requiring dose or frequency adjustment, additional monitoring, and/or selection of alternative therapy. Consult drug interactions database for more detailed information.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Sulfone products: Concomitant use of benzoyl peroxide with sulfone products (eg, dapsone, sulfacetamide) may cause temporary discoloration (yellow/orange) of facial hair and skin. Application of products at separate times during the day or washing off benzoyl peroxide prior to application of other products may avoid skin discoloration (Dubina 2009).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: For external use only; not for vaginal or ophthalmic use. Avoid contact with mucous membranes. Inform patients to use skin protection and minimize prolonged exposure to sun and avoid tanning beds or sun lamps.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13299059\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F152755\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=8950&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Dapsone (Topical): Benzoyl Peroxide may enhance the adverse/toxic effect of Dapsone (Topical). Specifically, the use of these agents in combination may cause skin and facial hair to temporarily turn a tan or yellow/orange color. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Erythromycin (Systemic): May diminish the therapeutic effect of Clindamycin (Topical).<i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Erythromycin (Topical): May diminish the therapeutic effect of Clindamycin (Topical).<i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Isotretinoin (Topical): Benzoyl Peroxide may diminish the therapeutic effect of Isotretinoin (Topical). <i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Neuromuscular-Blocking Agents: Clindamycin (Topical) may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents. <i> Risk C: Monitor therapy</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F152757\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">C (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F152767\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Animal reproduction studies have not been conducted with this combination. Refer to individual monographs. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F152768\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">It is not known if clindamycin or benzoyl peroxide are present in breast milk following topical administration. Due to the potential for serious adverse reactions in the breastfeeding infant, the manufacturers recommend a decision be made whether to discontinue breastfeeding or to discontinue the drug, taking into account the importance of treatment to the mother. Also refer to individual monographs.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F152751\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Benzoyl peroxide: Releases free-radical oxygen, which oxidizes bacterial proteins in the sebaceous follicles, decreasing the number of anaerobic bacteria and decreasing irritating-type free fatty acids.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Clindamycin: Reversibly binds to 50S ribosomal subunits preventing peptide bond formation thus inhibiting bacterial protein synthesis; bacteriostatic or bactericidal depending on drug concentration, infection site, and organism.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F152764\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:0em;display:inline\">See individual agents. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F152766\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (Acanya External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1.2-2.5% (50 g): $633.01</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (BenzaClin External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1-5% (25 g): $307.60</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (BenzaClin with Pump External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1-5% (35 g): $430.76</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (Clindamycin Phos-Benzoyl Perox External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1-5% (50 g): $425.35</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1.2-5% (45 g): $203.44</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (Duac External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1.2-5% (45 g): $423.00</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (Neuac External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1.2-5% (45 g): $552.78</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (Onexton External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1.2-3.75% (50 g): $633.01</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Kit</b> (Neuac External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1.2-5% (130 g): $552.78</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F854893\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Benzaclin (MX);</li>\n      <li>Benzalin (IL);</li>\n      <li>Benzolac-CL (HK, ID);</li>\n      <li>Clidan B (AR, UY);</li>\n      <li>Clindacur (AR);</li>\n      <li>Clindapack (MX);</li>\n      <li>Clindoxyl (AR, BR);</li>\n      <li>Clindoxyl Gel (DK, FI);</li>\n      <li>Clindoxyl Once Daily (SG);</li>\n      <li>Duac (BB, HR, IS, JP, KR, LB, LT, LV, RO, SI, SK, VN);</li>\n      <li>DUAC (CH, CZ, DE, EE, ES, GB, IE, IL, MT, MY, NL, NZ, PH, PL, PT, SE, TH);</li>\n      <li>Duac Once Daily (AU, HK, TH, TW);</li>\n      <li>Freeacne Gel (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Indoxyl (EC, TR);</li>\n      <li>Indoxyl Gel (CL, CO, GR, MX, PE, PY);</li>\n      <li>Klina (CL);</li>\n      <li>Sinac (CO)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Acanya (clindamycin/benzoyl peroxide) [prescribing information]. Bridgewater, NJ: Valeant Pharmaceuticals; October 2016.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Benzaclin (clindamycin/benzoyl peroxide) [prescribing information]. Bridgewater, NJ: Valeant Pharmaceuticals; Feruary 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Duac (clindamycin/benzoyl peroxide) [prescribing information]. Research Triangle Park, NC: Stiefel Laboratories; April 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Dubina MI, Fleischer AB Jr. Interaction of topical sulfacetamide and topical dapsone with benzoyl peroxide. <i>Arch Dermatol</i>. 2009;145(9):1027-1029. doi:10.1001/archdermatol.2009.186.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/clindamycin-and-benzoyl-peroxide-drug-information/abstract-text/19770443/pubmed\" target=\"_blank\" id=\"19770443\">19770443</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Leyden JJ, Thiboutot D, Shalita A. Photographic review of results from a clinical study comparing benzoyl peroxide 5%/clindamycin 1% topical gel with vehicle in the treatment of rosacea. <i>Cutis. </i>2004;73(6 Suppl):11-17.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/clindamycin-and-benzoyl-peroxide-drug-information/abstract-text/15228129/pubmed\" target=\"_blank\" id=\"15228129\">15228129</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Neuac (clindamycin/benzoyl peroxide) [prescribing information]. Allegan, MI: Perrigo; November 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Onexton (clindamycin/benzoyl peroxide) [prescribing information]. Bridgewater, NJ: Valeant Pharmaceuticals; October 2016.</div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 8950 Version 123.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F152776\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F854892\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F152791\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F152779\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F152786\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F152780\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F50109320\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F50109321\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F152760\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F152748\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F152762\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F152761\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Use: Off-Label\" href=\"#F25873030\" class=\"outlineLink\">Use: Off-Label</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F152754\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F152765\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F152752\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13299059\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F152755\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F152757\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F152767\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F152768\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F152751\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F152764\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F152766\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F854893\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/8950|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=clindamycin-and-benzoyl-peroxide-patient-drug-information\" class=\"drug drug_patient\">Clindamycin and benzoyl peroxide: Patient drug information</a></li><li><a href=\"topic.htm?path=clindamycin-and-benzoyl-peroxide-pediatric-drug-information\" class=\"drug drug_pediatric\">Clindamycin and benzoyl peroxide: Pediatric drug information</a></li></ul></div></div>","javascript":null}